Corvus Pharmaceuticals (CRVS)
(Delayed Data from NSDQ)
$5.20 USD
+0.02 (0.39%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $5.19 -0.01 (-0.19%) 7:06 PM ET
3-Hold of 5 3
C Value B Growth A Momentum B VGM
Brokerage Reports
0 items in cart
Corvus Pharmaceuticals, Inc. [CRVS]
Reports for Purchase
Showing records 121 - 140 ( 154 total )
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE - The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - ASCO Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Corvus'' ASCO Update. We''re Getting Closer - Next Stop, SITC
Provider: Roth Capital Partners, Inc.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
First Look at CPI-006; Evidence of Broader Immune Effects for CD73
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
The Week Ahead in Life Sciences
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - An Ode to the Tumor Microenvironment
Provider: Roth Capital Partners, Inc.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
We are initiating coverage with a Buy rating and a $6 PT
Provider: Roth Capital Partners, Inc.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology- ASCO Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q4 Financials; ITK inhibitor CPI-818 Moves into Clinic
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
SITC 2018 Abstract Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; Clinical Update at SITC for CPI-444
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
MORNING CALL
Provider: WEDBUSH SECURITIES INC.
Company: Corvus Pharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Biotechnology - ESMO 2018 Roundup for Covered Companies
Provider: WEDBUSH SECURITIES INC.
Analyst: NIERENGARTEN D